- MCTC
Holdings Inc. is engaged in developing infusion technologies, including
nanoparticles, for making hemp extracts more bioavailable to users through
the bloodstream
- The
company has a particular goal of promoting beverage infusion superior to
anything existing in the industry as a potential replacement for alcohol
and alcohol’s negative health effects
- MCTC
has filed its fifth patent under its Hemp You Can Feel brand after lab
results exceeded the company’s expectations for demonstrating cannabis
particle infusion on a minuscule, undetectable basis
Cannabinoid science innovator MCTC
Holdings Inc. (OTC: MCTC), a Delaware-registered, fully reporting company,
has applied for what would be its fifth patent even as laboratory results
indicate its revolutionary Hemp You Can Feel™ brand technology has exceeded
expectations when it comes to infusing beverages, powders and liquid
concentrates to such a degree that all hemp extracts and major cannabinoids are
undetectable.
“We believe the uses for this advanced infusion technology
are many, especially as a replacement for alcohol in various beverages,” MCTC
Holdings CEO Arman Tabatabaei stated in a news release (http://ibn.fm/clSAc).
The Hemp You Can Feel innovation was introduced last month
as a beverage industry solution for delivering relaxation to consumers without
the negative health effects associated with alcohol consumption. The brand’s
technology is based on an all-natural manufacturing process that doesn’t depend
on any chemical surfactants, stabilizers or additives.
MCTC Holdings has been experimenting with cannabis-based
polymeric solid nanoparticles and nanofibers, and while the company’s latest
step forward involves non-nanoparticle technologies, they do nonetheless
demonstrate chemical property levels many magnitudes lower than those typically
seen in the marketplace.
The food and medical industries have long used nanoparticles
to turn extremely small substances into rapid delivery mechanisms that can
bypass the digestive system and go straight for the bloodstream, and the
science is ripe with potential for cannabis applications. MCTC’s technology
makes it possible to use very small amounts of extracts to achieve similar or
superior results compared to other infusion methods.
MCTC plans to use the technology in products it expects to
launch during the coming months as well as using it for the basis of a
licensing strategy that will allow other companies to build branding from it on
a “white label” manufacturing base at MCTC’s licensed Los Angeles facility.
The company announced December 12 it was filing for a new
patent subsequent to the positive test results.
“We have produced some spectacular results and test data on
this new technology and we are in discussions with several companies that are
planning product introductions based on Hemp You Can Feel technology,”
Tabatabaei stated (http://ibn.fm/bJ5AY).
“This marks our 5th patent with several more expected over the short term.”
Tabatabaei stated the next step for the company will be to
create microparticle and nanoparticle forms of Hemp You Can Feel, and that
development work has already begun toward that end. The company is also in the
process of developing nanoparticle creation protocols for the cannabinol (CBN)
extract and tetrahydrocannabivarin (THC-V) compound.
CBN is found only in small amounts and mostly results from
oxidation of the other cannabinoids in cannabis, making it difficult to obtain
and expensive as a result. An effective, minuscule-amount-tapping technology
could make its use more cost-effective. THC-V is similar to
tetrahyrdrocannabinol in molecular structure but has different outcomes, such
as appetite suppression and bone-growth promotion (http://ibn.fm/2UUlu).
“We think these new microparticle and nanoparticle
technologies could prove very useful for advanced food and beverage infusion,”
Tabatabaei stated. “We believe this additional area of research is especially
topical considering the recent warnings put forth by the U.S. Food and Drug
Administration concerning the use of CBD in foods and beverages.”
On November 25, the FDA announced a warning to more than a
dozen companies for illegally selling products containing cannabidiol (CBD) in
ways that violate the Federal Food, Drug, and Cosmetic Act, including marketing
CBD products to treat diseases or for other therapeutic uses for humans or for
animals.
Under the FD&C Act, a product qualifies as a drug if it
claims to treat a disease or to have some other therapeutic or medical use, and
is intended to affect the structure or function of the human or animal body
other than for simple alimentary purposes. No CBD-based “drug” has been
approved on a federal basis except for one company’s prescription to treat
rare, severe forms of epilepsy in humans, so other CBD products marketed on an
interstate basis may be found in violation, according to the FDA’s news
release (http://ibn.fm/U8Ory).
For more information, visit the company’s website at www.CannabisGlobalInc.com
NOTE TO INVESTORS: The latest news and updates
relating to MCTC are available in the company’s newsroom at http://ibn.fm/MCTC
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment